Palustrin-Ca

General Information


DRACP ID  DRACP03502

Peptide Name   Palustrin-Ca

Sequence  GFLDIIKDTGKEFAVKILNNLKCKLAGGCPP

Sequence Length  31

UniProt ID  C5IB03 

PubChem CID  Not available

Origin  Animalia

Type  Native peptide

Classification

  

Active ACP



Activity Information


Hemolytic Activity  Not available

Normal (non-cancerous) Cytotoxicity  Not available

Target  Not available

Affinity  Not available

Mechanism  Not available

Nature  Anticancer; Antibacterial; Antifungal



Structure Information


PDB ID  Not available

Predicted Structure  DRACP03502

Helicity  Not available

Linear/Cyclic  Linear

Disulfide/Other Bond  Not available

N-terminal Modification  Free

C-terminal Modification  Free

Other Modification  None

Chiral  L



Physicochemical Information


Formula  C150H248N38O41S2

Absent amino acids  HMQRSWY

Common amino acids  K

Mass  383929

Pl  8.8

Basic residues  5

Acidic residues  3

Hydrophobic residues  12

Net charge  2

Boman Index  -1347

Hydrophobicity  14.84

Aliphatic Index  103.87

Half Life 
  Mammalian: 1 hour
  Yeast: 2 min
  E.coli: 2 min

Extinction Coefficient cystines  125

Absorbance 280nm  4.17

Polar residues  9

Amino acid distribution



Literature Information


Literature 1

Pubmed ID Not available

Title  Effects of Two Novel Peptides from Skin of Lithobates Catesbeianus on Tumor Cell Morphology and Proliferation

Doi Not available

Year  2011

Patent

Patent ID Not available

Patent Title  Not available

Other Iinformation  Not available

Other Published ID  Not available




DBAASP ID  5841

DRACP is developed by Dr.Zheng's team.